Form SB-2 - Optional form for registration of securities to be sold to the public by small business issuers:
SEC Accession No. 0000927016-97-002766
Filing Date
1997-10-29
Accepted
1997-10-29 00:00:00
Documents
7
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM SB-2 SB-2 316144
2 LETTER AGREEMENT DATED 8/27/97 EX-10.23 4832
3 PROMISSORY NOTE FOR J. MELVILLE ENGLE EX-10.25 3325
4 STATEMENT OF COMPUTATION OF PER SHARE EARNINGS EX-11.1 3513
5 CONSENT OF INDEPENDENT ACCOUNTANTS EX-23.1 418
6 CONSENT OF HAMILTON, BROOK, SMITH & REYNOLDS, P.C. EX-23.3 706
7 FINANCIAL DATA SCHEDULE EX-27 2063
  Complete submission text file 0000927016-97-002766.txt   333173
Mailing Address 236 WEST CUMMINGS PARK WOBURN MA 01801
Business Address 236 WEST CUMMINGS PARK WOBURN MA 01801 6179326616
ANIKA THERAPEUTICS INC (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: MA | Fiscal Year End: 0831
Type: SB-2 | Act: 33 | File No.: 333-38993 | Film No.: 97703039
SIC: 2836 Biological Products, (No Diagnostic Substances)